Published in Dev Neurosci on January 01, 2002
Variable global dysconnectivity and individual differences in schizophrenia. Biol Psychiatry (2011) 1.51
Quantitative tract-specific measures of uncinate and cingulum in major depression using diffusion tensor imaging. Neuropsychopharmacology (2011) 1.08
Is being plastic fantastic? Mechanisms of altered plasticity after developmental traumatic brain injury. Dev Neurosci (2006) 1.02
The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia. Int J Geriatr Psychiatry (2008) 0.97
Graph theory analysis of cortical-subcortical networks in late-life depression. Am J Geriatr Psychiatry (2013) 0.93
White matter tract integrity of anterior limb of internal capsule in major depression and type 2 diabetes. Neuropsychopharmacology (2013) 0.88
COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study. Neuropsychiatr Dis Treat (2014) 0.82
White matter fiber compromise contributes differentially to attention and emotion processing impairment in alcoholism, HIV-infection, and their comorbidity. Neuropsychologia (2012) 0.81
Conversion disorder in women with the FMR1 premutation. Am J Med Genet A (2009) 0.81
Relation between variants in the neurotrophin receptor gene, NTRK3, and white matter integrity in healthy young adults. Neuroimage (2013) 0.80
Evaluation of quantitative EEG by classification and regression trees to characterize responders to antidepressant and placebo treatment. Open Med Inform J (2011) 0.78
Microstructural abnormalities in white and gray matter in obese adolescents with and without type 2 diabetes. Neuroimage Clin (2017) 0.75
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry (2011) 3.34
Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology (2013) 2.62
Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry (2002) 2.39
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety (2012) 2.23
Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evid Based Complement Alternat Med (2007) 2.22
Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry (2005) 1.99
American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry (2007) 1.79
A web-based data management system to improve care for depression in a multicenter clinical trial. Psychiatr Serv (2002) 1.48
Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry (2004) 1.42
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res (2009) 1.40
Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. J Clin Psychopharmacol (2010) 1.29
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res (2009) 1.18
Biomarkers to predict antidepressant response. Curr Psychiatry Rep (2010) 1.14
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial. Epilepsy Behav (2011) 1.11
fMRI activation in the amygdala and the orbitofrontal cortex in unmedicated subjects with major depressive disorder. Psychiatry Res (2010) 1.10
Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. J Psychiatr Res (2009) 1.09
Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression. Neurosurg Clin N Am (2011) 1.04
Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clin Neurophysiol (2004) 1.03
Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol (2009) 1.01
Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry (2006) 0.96
Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry (2006) 0.93
Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl) (2004) 0.93
A new paradigm for the prediction of antidepressant treatment response. Dialogues Clin Neurosci (2009) 0.93
The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front Hum Neurosci (2013) 0.92
Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clin Neurophysiol (2003) 0.92
A genome-wide association study of a sustained pattern of antidepressant response. J Psychiatr Res (2013) 0.90
Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr (2008) 0.89
Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol (2009) 0.89
Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry (2005) 0.87
Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. PLoS One (2012) 0.87
Relationship between medical student perceptions of mistreatment and mistreatment sensitivity. Med Teach (2012) 0.86
A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry (2014) 0.86
Baroreflex mechanisms in major depression. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.86
The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Psychiatr Clin North Am (2007) 0.86
Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics (2005) 0.85
Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Res (2011) 0.82
Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology (Berl) (2015) 0.81
Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clin EEG Neurosci (2008) 0.81
Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology (2005) 0.80
Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Ann N Y Acad Sci (2015) 0.80
Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci (2009) 0.80
Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? J Neuropsychiatry Clin Neurosci (2013) 0.79
Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. J Clin Psychopharmacol (2010) 0.79
Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psychooncology (2014) 0.79
Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas (2006) 0.79
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice. CNS Spectr (2013) 0.79
The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. J Clin Neurophysiol (2011) 0.78
Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Clin EEG Neurosci (2009) 0.78
Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: An Updated Systematic Review and Meta-analysis. J ECT (2016) 0.78
Manipulation of cigarette craving with transcranial magnetic stimulation. Biol Psychiatry (2011) 0.77
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. J Affect Disord (2011) 0.77
Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology (2005) 0.77
Pretreatment neurophysiologic function and ECT response in depression. J ECT (2004) 0.76
Does prior antidepressant treatment of major depression impact brain function during current treatment? Eur Neuropsychopharmacol (2012) 0.76
Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography. Clin EEG Neurosci (2010) 0.76
Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Med (2009) 0.76
Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. J Neuropsychiatry Clin Neurosci (2006) 0.76
Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'. J Psychopharmacol (2012) 0.75
Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes? Med Hypotheses (2013) 0.75